Advertisement
Home Tags Blood Disorders

Tag: Blood Disorders

An antibody fragment

Idarucizumab Deemed Effective for Dabigatran Reversal

Findings among patients with serious bleeding or who require an urgent procedure
The drug elotuzumab reduces the risk of cancer progression and mortality by 30 percent when combined with the standard two-drug therapy for multiple myeloma

ASCO: Elotuzumab Shows Benefit in Multiple Myeloma

Survival gains when elotuzumab was added to treatment
Articles relating to malignant hematology

High-Value Research of 2014 Presented for Hematology

Author summarizes 2014 studies that are highly relevant to hematology
Raplixa (human fibrin sealant) has been approved by the U.S. Food and Drug Administration to help control bleeding during surgery

FDA Approves Raplixa to Help Control Surgical Bleeding

Spray-dried fibrin sealant promotes clotting when other methods are 'ineffective or impractical'
The case of an 8-year-old Canadian boy suggests that it's possible

Case Report of Food Allergy Acquired Via Blood Transfusion

Doctors need to be aware of the possibility of 'passive transfer'
For patients with facet joint arthropathy

AAPM: Platelet-Rich Plasma Offers Short-Term Benefit

Short-term benefit for patients with facet joint arthropathy, which is not sustained after 90 days
Higher total white blood cell and neutrophil counts are independent predictors of stroke in older Japanese-American men

WBC, Neutrophil Counts Predict Stroke Risk in Older Asian Men

Higher total WBC, neutrophil counts independently predict stroke in older Japanese-American men
Blood that's been stored for a few weeks is just as beneficial as fresh blood for patients with life-threatening conditions who require transfusions

Old Blood As Good As Fresh in Critically Ill Patients

Trial shows that changes to blood during storage do not affect quality
For patients undergoing nonemergency cardiac surgery

Restrictive Transfusion Threshold No Better Post Cardiac Surgery

Restrictive threshold not superior to liberal threshold for morbidity, health care costs
A novel oral substrate reduction therapy

Eliglustat Safely Reverses Manifestations of Gaucher’s

Significant improvement in spleen volume for untreated adults with type 1 disease